Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
FT819 in Subjects With B-cell MalignanciesB-cell chronic lymphocytic leukemia, B-cell neoplasm, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, neoplasm, precursor B-cell acute lymphoblastic leukemiaActive, not recruitingPhase 12026-03-19NCT04629729

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Fate Therapeutics7

18 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Hackensack University Medical CenterHackensackUnited States308
Mayo ArizonaPhoenixUnited States2
Mayo FloridaJacksonvilleUnited States1
Mayo MinnesotaRochesterUnited States1
MD Anderson Cancer CenterHoustonUnited States589
Memorial Sloan Kettering Cancer CenterNew YorkUnited States60
Norton Cancer Institute, St. Matthews CampusLouisvilleUnited States9
Oregon Health & Sciences UniversityPortlandUnited States9
Scripps Green HospitalLa JollaUnited States14
Stanford Cancer InstitutePalo AltoUnited States21
The University of Kansas Cancer CenterWestwoodUnited States31
UC DavisDavisUnited States1
UCLA Ronald Reagan Medical CenterLos AngelesUnited States6
University of Alabama at BirminghamBirminghamUnited States247
University of FloridaGainesvilleUnited States70
University of IowaIowa CityUnited States284
University of Nebraska Medical CenterOmahaUnited States397
University of Wisconsin-MadisonMadisonUnited States8